Trial Profile
Bleeding Profile With Continuous Hormone Replacement Therapy in Postmenopausal Women: A Prospective, Open, Multicenter Trial of Activelle Treatment Following Switch From Trisekvens
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol/norethisterone (Primary)
- Indications Menopausal syndrome; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 28 Apr 2015 New trial record